Brigit Biofarmaka Teknologi Tbk. vs Dana Brata Luhur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Dana Brata Luhur Tbk. trades at Rp1,100 (market cap 1.43T, 1.58M 24h volume). The key difference: Dana Brata Luhur Tbk. is far larger — about 8.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Dana Brata Luhur Tbk. is more actively traded (1.58M versus 218.7K). Which is the better fit depends on your goals.
| OBAT | TEBE | |
|---|---|---|
Market Cap | 172.82B | 1.43T |
Volume | 218.7K | 1.58M |
Lot | 2.19K | 15.82K |
Turnover | 53.51M | 1.74B |
Average Price | 244.66 | 1,101.03 |
Value | 53.51M | 1.74B |
Indicative Equilibrium Price | 252 | 1,100 |
Indicative Equilibrium Volume | 48 | 214 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Dana Brata Luhur Tbk (the Company) was established based on Notarial Deed No. 52 dated June 26, 2008 of Bonar Sihombing, S.H., a public notary in Jakarta and the Deed of Amendment on the Articles of Association No. 2 dated December 18, 2008.
Read more on TEBE →